{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:16:36Z","timestamp":1790716596895,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005849","name":"Baqiyatallah University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37556","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:11:07Z","timestamp":1725635467000},"page":"e37556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population"],"prefix":"10.1016","volume":"10","author":[{"given":"Fereshteh","family":"Khalili-Moghadam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Hosseini Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taleb","family":"Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Gharechahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37556_bib1","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.heliyon.2024.e37556_bib2","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-101921-035222","article-title":"Immune activation in alzheimer disease","volume":"42","author":"Mary","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","article-title":"Is Alzheimer disease a disease?","volume":"20","author":"Korczyn","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.heliyon.2024.e37556_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e37556_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2006-9S338","article-title":"Segregation of a missense mutation in the amyloid beta-protein precursor gene with familial Alzheimer's disease","volume":"9","author":"Goate","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.heliyon.2024.e37556_bib9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e37556_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/5.7.985","article-title":"Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant","volume":"5","author":"Sherrington","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","article-title":"Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes","volume":"53","author":"Schwartzentruber","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281440","article-title":"What does heritability of Alzheimer's disease represent?","volume":"18","author":"Baker","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e37556_bib15","doi-asserted-by":"crossref","first-page":"220 e1","DOI":"10.1016\/j.neurobiolaging.2017.07.001","article-title":"Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls","volume":"59","author":"Bellenguez","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e37556_bib16","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e37556_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37556_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt187","article-title":"Evidence for impaired amyloid beta clearance in Alzheimer's disease","volume":"5","author":"Wildsmith","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.heliyon.2024.e37556_bib19","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1074\/jbc.M116.755264","article-title":"Familial Alzheimer's disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-beta peptide","volume":"292","author":"Hatami","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e37556_bib20","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e37556_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e37556_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e37556_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/NEN.0b013e3182345e46","article-title":"Abeta-degrading enzymes: potential for treatment of Alzheimer disease","volume":"70","author":"Miners","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2007.03.072","article-title":"Neprilysin protects neurons against Abeta peptide toxicity","volume":"1152","author":"El-Amouri","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2024.e37556_bib25","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1111\/febs.16939","article-title":"Molecular basis of selective amyloid-beta degrading enzymes in Alzheimer\u2019s disease","volume":"291","author":"Zukowska","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.heliyon.2024.e37556_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sageke.2003.3.pe1","article-title":"Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism","volume":"2003","author":"Saito","year":"2003","journal-title":"Sci. Aging Knowl. Environ."},{"key":"10.1016\/j.heliyon.2024.e37556_bib27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e37556_bib28","first-page":"30","article-title":"Genetic variation in MME in relation to neprilysin protein and enzyme activity, Abeta levels, and Alzheimer's disease risk","volume":"3","author":"Miners","year":"2012","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.heliyon.2024.e37556_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2017.07.060","article-title":"Meta-analysis of expression and function of neprilysin in Alzheimer's disease","volume":"657","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e37556_bib30","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1523\/JNEUROSCI.2984-08.2009","article-title":"Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice","volume":"29","author":"Meilandt","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37556_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neulet.2007.09.019","article-title":"Association between neprilysin polymorphisms and sporadic Alzheimer's disease","volume":"427","author":"Wood","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e37556_bib32","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s12035-015-9411-z","article-title":"Neprilysin confers genetic susceptibility to Alzheimer's disease in han Chinese","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"Gonzalez","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2024.e37556_bib34","article-title":"The Association between Neprilysin gene polymorphisms and Alzheimer's disease in Tibetan population","volume":"11","author":"Chen","year":"2020","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.heliyon.2024.e37556_bib35","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/jnnp.2004.036574","article-title":"Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients","volume":"75","author":"Helisalmi","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e37556_bib36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00702-002-0807-3","article-title":"Possible increased risk for Alzheimer's disease associated with neprilysin gene","volume":"110","author":"Clarimon","year":"2003","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.heliyon.2024.e37556_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000076351","article-title":"Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease","volume":"17","author":"Sakai","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.heliyon.2024.e37556_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3940(02)00057-5","article-title":"Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease","volume":"320","author":"Oda","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e37556_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/s0304-3940(02)01300-9","article-title":"No association between polymorphisms in the neprilysin promoter region and Swedish Alzheimer's disease patients","volume":"337","author":"Lilius","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e37556_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon 4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.heliyon.2024.e37556_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","article-title":"A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease","volume":"68","author":"Coon","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e37556_bib42","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e37556_bib43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000333006","article-title":"Genetic and functional effects of membrane metalloendopeptidase on diabetic nephropathy development","volume":"34","author":"Zhang","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2014.07.064","article-title":"Meta-analysis of the association between two neprilysin gene polymorphisms and Alzheimer's disease","volume":"346","author":"Guo","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.heliyon.2024.e37556_bib45","first-page":"47","article-title":"Evaluation of neprilysin sequence variation in relation to CSF beta-Amyloid levels and Alzheimer disease risk","volume":"1","author":"Blomqvist","year":"2010","journal-title":"Int J Mol Epidemiol Genet"},{"key":"10.1016\/j.heliyon.2024.e37556_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","article-title":"Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form","volume":"350","author":"Kanemitsu","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2024.e37556_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jnr.10390","article-title":"Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging","volume":"70","author":"Iwata","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.heliyon.2024.e37556_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.105.095687","article-title":"Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory","volume":"317","author":"Zou","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e37556_bib49","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2353\/ajpath.2008.070620","article-title":"Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease","volume":"172","author":"El-Amouri","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neurobiolaging.2006.10.010","article-title":"Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels","volume":"29","author":"Hellstrom-Lindahl","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2024.e37556_bib51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","article-title":"Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain","volume":"115","author":"Wang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e37556_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.24612","article-title":"Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2","volume":"79","author":"Higuchi","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heliyon.2024.e37556_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1913","article-title":"A nonsense mutation in MME gene associates with autosomal recessive late-onset Charcot-Marie-Tooth disease","volume":"10","author":"Jamiri","year":"2022","journal-title":"Mol Genet Genomic Med"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024135876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024135876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:36:55Z","timestamp":1790714215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024135876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024135876"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37556","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37556"}}